Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Sanderson
Michael Sanderson
Merck & Co.
Medicine
Cancer research
Immunology
Refractory Multiple Myeloma
Oncology
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract 3774: Unraveling mechanisms of resistance to tepotinib and future treatment options
2020
Immunology
Linda Pudelko
Frank Jaehrling
C. Stroh
Nina Linde
Michael Sanderson
Doreen Musch
Marina Keil
Christina Esdar
Andree Blaukat
Niki Karachaliou
Show All
Source
Cite
Save
Citations (0)
Quantitative PK/PD Prediction of the Efficacious and Safe Dose Ranges of the LMP7 Inhibitor M3258 for Phase I Application in Relapsed/Refractory Multiple Myeloma Patients
2019
Blood
Florian Lignet
Christina Esdar
Manja Friese-Hamim
Andreas Becker
Elise Drouin
Samer El Bawab
Samantha Goodstal
Claude Gimmi
Phlipp Haselmayer
Frank Jährling
Michael Sanderson
Willem Sloot
Sofia Stinchi
Anja Victor
Gina Walter
Felix Rohdich
Show All
Source
Cite
Save
Citations (1)
Pharmacological Perturbation of the Immunoproteasome in Hematologic Neoplasias: Therapeutic Implications
2019
Blood
Sondra L. Downey-Kopyscinski
Ricardo De Matos Simoes
Megan Bariteau
Minasri Borah
Sam Bender
Janaka Foneska
Jennifer Roth
Richard W.J. Groen
Gina Walter
Manja Friese-Hamim
Samantha Goodstal
Michael Sanderson
Constantine S. Mitsiades
Show All
Source
Cite
Save
Citations (1)
1